Clinical Trials Logo

Alcoholic Cirrhosis clinical trials

View clinical trials related to Alcoholic Cirrhosis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04070508 Withdrawn - Clinical trials for Alcohol Use Disorder

Early Detection of Alcoholic Liver Disease

Start date: April 1, 2023
Phase:
Study type: Observational [Patient Registry]

This is an observational study to identify the prevalence of advanced liver fibrosis among patients with excessive alcohol intake using a non-invasive method (FibroScan®) and to characterize the main environmental, genetic and epigenetic factors that could influence the development of advanced fibrosis. The investigators will include patients 21 years of age or older with excessive alcohol intake, with abnormal AST, ALT, GGT and/or bilirubin, and without any evidence of decompensated liver disease (jaundice, ascites, encephalopathy). Liver fibrosis will be estimated by FibroScan®. A designed questionnaire for studying environmental and psychosocial factors will be filled by the included patients, and blood samples will be obtained to study genetic and epigenetic factors. The patients with advance fibrosis will be referred to the specialist for surveillance and treatment according to current clinical guidelines.